Blood Disorders: More Than Just a Diagnosis – Malaika Mehboob
Malaika Mehboob, Student Ambassador of Physiogic, shared on LinkedIn:
”Blood Disorders: More Than Just a Diagnosis
Blood disorders encompass a wide spectrum of conditions affecting red blood cells, white blood cells, platelets, and clotting factors.
From anemia, which impairs oxygen delivery, to hemophilia and clotting disorders that disrupt normal hemostasis, each condition reflects a unique pathophysiological mechanism.
Genetic disorders like sickle cell disease and thalassemia highlight how molecular changes in hemoglobin can significantly impact quality of life, while conditions such as leukemia and autoimmune blood diseases demonstrate the complex interplay between the immune system and hematopoiesis.
Polycythemia and platelet deficiencies further remind us how imbalance, whether excess or deficiency, can lead to serious clinical consequences.
Early diagnosis, evidence-based management, and patient education remain critical in improving outcomes.
As healthcare professionals and students, understanding these disorders at a cellular and clinical level is essential for delivering holistic and compassionate care.
Continuous learning in hematology isn’t optional; it’s vital.”
Stay updated with Hemostasis Today.
-
Feb 25, 2026, 16:47Alan Nurden: Platelet Defects Explain Bleeding in EHDS Patients
-
Feb 25, 2026, 16:40Mohammed Almohammadi: Uniting Leaders in Laboratory Hematology at the 1st Saudi ISLH Joint Conference
-
Feb 25, 2026, 16:37Salihu Asimawu: Inflammation Is Not a Disease – Hats Off to the Heroes Inside Us
-
Feb 25, 2026, 16:34Michael Makris: Biomarin Has Decided to Withdraw Roctavian from the Market
-
Feb 25, 2026, 16:25Tagreed Alkaltham: The Blood Banker Personality
-
Feb 25, 2026, 16:17Sanjay Ahuja: Insightful Talk on 100 Years of VWD by Jorge Di Paola
-
Feb 25, 2026, 15:20Michael Shapiro։ Creating Real Pathways for Trainees in Preventive Cardiology
-
Feb 25, 2026, 15:15Ajay Kumar: Plasma Component Quality Control Standards
-
Feb 25, 2026, 15:09Wolfgang Miesbach: Efficacy, Safety and Thrombosis Signals in Haemophilia A/B with Inhibitors